Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: A single-arm, open-label clinical trial-Reference-Cited by-同舟云学术

Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: A single-arm, open-label clinical trial

Published:2024-07 Issue:7 Volume:30 Page:597-602
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Takazono Takahiro^ORCID,Hosogaya Naoki,Fukushima Koki,Morio Ryosuke,Irifune Satoshi,Miyamura Takuto,Harada Yosuke,Nagayoshi Yosuke,Kondo Akira,Mihara Tomo,Fukuda Yuichi,Sasaki Eisuke,Sawai Toyomitsu,Imamura Yoshifumi,Morikawa Toru,Futsuki Yoji,Inoue Yuichi,Fukushima Kiyoyasu,Suyama Naofumi,Tanaka Hikaru,Hanaka Tetsuya,Shimabukuro Ikuko,Hata Ryosuke,Ota Kenji^ORCID,Morimoto Shimpei,Nakada Nana,Ito Yuya,Yoshida Masataka,Takeda Kazuaki^ORCID,Ide Shotaro,Iwanaga Naoki^ORCID,Nemoto Kazuki,Funada Midori,Izumikawa Koichi,Yatera Kazuhiro^ORCID,Yanagihara Katsunori,Mukae Hiroshi^ORCID

Funder

Kyorin Pharmaceutical

Publisher

Elsevier BV

Reference15 articles.

1. LaW. Trends in Death Rates for Leading Causes of Death,2009

2. Microbiological and clinical aspects of aspiration pneumonia;Lode;J Antimicrob Chemother,1988

3. The significance of oral streptococci in patients with pneumonia with risk factors for aspiration: the bacterial floral analysis of 16S ribosomal RNA gene using bronchoalveolar lavage fluid;Akata;BMC Pulm Med,2016

4. In vitro activities and spectrum of the novel fluoroquinolone lascufloxacin (KRP-AM1977);Kishii;Antimicrob Agents Chemother,2017

5. In vitro activity of lascufloxacin, a novel fluoroquinolone antibacterial agent, against various clinical isolates of anaerobes and Streptococcus anginosus group;Yamagishi;Anaerobe,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal effects of lascufloxacin on human gut and salivary microbiota: Analysis using next-generation sequencing method;Journal of Infection and Chemotherapy;2024-07